News

Jardiance tabs from Boehringer Ingelheim and Eli Lilly now available

BY Ryan Chavis

RIDGEFIELD, Conn., and INDIANAPOLIS — Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co. announced that Jardiance (empagliflozin) tablets are now available by prescription in pharmacies across the United States. The Food and Drug Administration approved the drug on Aug. 1 as an addition to diet and exercise to improve glycemic control or blood-glucose levels in adults with Type 2 diabetes.

“As a testament to the joint commitment by Boehringer Ingelheim and Lilly to improve care for people with diabetes, our alliance is proud to make Jardiance available so quickly following its approval by the FDA,” said Kathleen Dowd, SVP, marketing, Boehringer Ingelheim Pharmaceuticals. “We believe Jardiance is an exciting new treatment option with the potential to help many of the millions of adults with type 2 diabetes who have difficulty controlling their blood sugar levels.”

Jardiance once-daily tablets are availbale in 10-mg or 25-mg dosage strengths. The drug is not indicated for people with Type 1 diabetes or for people with diabetic ketoacidosis, the companies stated.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Study: Medication reviews help ensure proper medication management

BY David Salazar

TORONTO — A new report by Shoppers Drug Mart and Canadian nonprofit CARP is shining a light on a key role pharmacists can play in helping patients understand the medicine they’re taking. The report highlights the importance of medication reviews by pharmacists that can help customers taking several medications aware of potential side effects and interactions.

To compile the report, researchers interviewed about 500 Canadians who had been to a medication review with a Shoppers Drug Mart pharmacist in the past month. Among those surveyed, 43% said they had a better understanding of interactions between medications, and 36% said they grasped potential side effects better as a result of their review.

Additionally, 83% said their review made remembering to take their medication properly easier, and 82% were more confident in managing them. Some 85% said they were interested medication reviews becoming a routine part of their medication management.

As part of an effort to manage and prevent possible issues with drug therapy, 79% of physicians surveyed for the report said they were in favor of expanding pharmacists’ roles. Over half said that the pharmacist’s role is ensuring drugs are taken properly. Pharmacists reported that when they made home medication reviews for patients 40% weren’t taking their medication as directed.

For the companies that sponsored the report, the key to making medication reviews more widely available is through funding.

“This new report includes data demonstrating both the public and medical professionals see the value in pharmacists conducting medication reviews,” Domenic Pilla, president of Shoppers Drug Mart said.  “Most of our provincial governments have begun to recognize the benefits and have instituted funding for this important pharmacy service.  We now have the opportunity to make the eligibility requirements and funding for this service more consistent across the entire country to improve patient care and safety.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Fera launches generic Moxatag

BY Ryan Chavis

NEW YORK — Fera Pharmaceuticals on Monday announced that it was selected by Pragma Pharmaceuticals to launch amoxicillin extended-release tablets, the authorized generic version of Moxatag.

“By having an authorized generic available, it is our hope that more patients will gain access to this once-a-day antibiotic therapy helping to ensure greater adherence and compliance," Craig Salmon, VP of sales at Fera, said.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES